ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 147 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $222,000 | +54.2% | 10,813 | +49.5% | 0.00% | – |
Q2 2023 | $144,000 | -92.0% | 7,234 | -93.1% | 0.00% | – |
Q1 2023 | $1,795,000 | +784.2% | 104,765 | +909.0% | 0.00% | – |
Q4 2022 | $203,000 | +2155.6% | 10,383 | +1848.0% | 0.00% | – |
Q3 2022 | $9,000 | -96.5% | 533 | -97.2% | 0.00% | – |
Q2 2022 | $259,000 | +547.5% | 18,829 | +643.3% | 0.00% | – |
Q1 2022 | $40,000 | -79.5% | 2,533 | -71.7% | 0.00% | – |
Q4 2021 | $195,000 | +91.2% | 8,941 | +162.3% | 0.00% | – |
Q3 2021 | $102,000 | -15.0% | 3,409 | +25.3% | 0.00% | – |
Q2 2021 | $120,000 | -92.5% | 2,720 | -92.4% | 0.00% | – |
Q1 2021 | $1,592,000 | +19800.0% | 35,886 | +26286.8% | 0.00% | – |
Q4 2020 | $8,000 | +300.0% | 136 | -9.3% | 0.00% | – |
Q1 2020 | $2,000 | -92.3% | 150 | -86.7% | 0.00% | – |
Q4 2019 | $26,000 | +62.5% | 1,124 | +77.0% | 0.00% | – |
Q3 2018 | $16,000 | -52.9% | 635 | -63.5% | 0.00% | – |
Q2 2018 | $34,000 | -24.4% | 1,741 | -27.3% | 0.00% | – |
Q1 2018 | $45,000 | – | 2,394 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 16,037,486 | $280,250,000 | 19.13% |
TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $52,015,000 | 9.58% |
Boxer Capital, LLC | 1,466,051 | $25,715,000 | 2.97% |
Ghost Tree Capital, LLC | 600,000 | $10,524,000 | 2.75% |
BRIDGER MANAGEMENT, LLC | 1,529,032 | $26,819,000 | 2.12% |
Cormorant Asset Management, LP | 1,700,000 | $29,818,000 | 2.02% |
EcoR1 Capital, LLC | 450,000 | $7,893,000 | 0.73% |
UNIVERSITY OF NOTRE DAME DU LAC | 171,015 | $3,000,000 | 0.67% |
Virtus ETF Advisers LLC | 17,799 | $312,000 | 0.66% |
SPHERA FUNDS MANAGEMENT LTD. | 290,001 | $5,087,000 | 0.46% |